Brazil Contraceptive Devices Market Report 2022 to 2030

Brazil Contraceptive Devices Market Analysis

$ 3999

Brazil's Contraceptive Devices Market is expected to witness growth from $323 Mn in 2022 to $643 Mn in 2030 with a CAGR of 9.00% for the forecasted year 2022-30. In Brazil, there has been an increase in demand for contraceptive devices as a result of the emphasis being placed on family planning and contraception education and awareness. The market is segmented by type and by gender. Some key players in this market include Farmoquimica, Famivita, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer, Pregna International, Eurofarma, and Teva Pharmaceutical.

ID: IN10BRMD005 CATEGORY: Medical Devices GEOGRAPHY: Brazil AUTHOR: Jigyasu Bhandari

Buy Now

Brazil Contraceptive Devices Healthcare Market Executive Analysis

Brazil's Contraceptive Devices Market size is at around $323 Mn in 2022 and is projected to reach $643 Mn in 2030, exhibiting a CAGR of 9.00% during the forecast period. Brazil's current health expenditures climbed (as a percentage of GDP) from 9.59% in 2019 to 10.02% in 2021. By 2040, Brazil's health expenditures will account for 12.6% of its GDP, with opportunities for expansion in sectors including basic care, hospital care, pharmaceuticals, long-term care, and administration. Brazil has a male life expectancy of 72.5 years and a female life expectancy of 79.5 years. Brazil's population is growing by 0.7% annually.

Brazil's maternal mortality rate was projected to be 48 deaths for every 100,000 live births in 2021. The number of persons living with HIV/AIDS in Brazil has been largely consistent in recent years, and by 2020, there will be 920,000 cases. To avoid unexpected pregnancies, contraceptive devices, commonly referred to as birth control devices, are frequently utilized in Brazil. Condoms, both male and female, are readily available in Brazil and are used to prevent pregnancy as well as to protect against STDs. Small, T-shaped devices called intrauterine devices are put into the uterus to stop pregnancy. Some of them can be used as long-term contraception for up to ten years. Small, flexible rods called hormonal implants are implanted beneath the skin of the upper arm. For up to three years, they release hormones that hinder conception. In Brazil, oral contraceptive tablets are a common method of birth control. They are taken every day and contain hormones that stop ovulation.

Brazil Contraceptive Devices Market Analysis

Market Dynamics

Market Growth Drivers

In Brazil, there has been an increase in demand for contraceptive devices as a result of the emphasis being placed on family planning and contraception education and awareness. The government of Brazil has been enacting policies to broaden access to contraceptive services, which has led to a rise in the demand for contraceptives. Brazil's improving standard of living has increased demand for premium contraceptive methods. This is especially true for women looking for trustworthy, efficient, and safe methods of contraception. The demand for contraceptives suited to the requirements of older women is rising as the Brazilian population ages. Hormone replacement treatment, which can assist women in managing their reproductive health, has seen an increase in demand as a result of this.

Market Restraints

Contraceptive devices are in high demand in Brazil, although access to them can be difficult in rural areas. This is because it's challenging for manufacturers to reach these markets due to things like a lack of transportation and infrastructure. There may be cultural or religious norms in some parts of Brazil that forbid the use of contraception. Due to the potential for decreased demand for contraceptive devices in these places, it may be challenging for manufacturers to grow their businesses there.

Competitive Landscape

Key Players

Farmoquimica (BR)
Libbs Farmaceutica (BR)
Famivita (BR)
Eurofarma (BR)
Mylan Laboratories
Church & Dwight
CooperSurgical
Pfizer
Pregna International
Teva Pharmaceutical

Recent Notable Deals

August 2021: In order to commercialise Nexplanon, Merck's contraceptive implant medicine, in Brazil, the multinational pharmaceutical corporation Merck partnered with Eurofarma, a Brazilian pharmaceutical company, in 2021. The alliance aims to strengthen Merck's position in Brazil and improve access to long-acting reversible contraceptives there.

Healthcare Policies and Regulatory Landscape

The Brazilian Health Regulatory Agency (ANVISA) and the Ministry of Health are in charge of the regulatory framework for contraceptive devices in the country. Contraceptive device production, importation, distribution, and use in Brazil are all subject to ANVISA regulation and oversight, while family planning and reproductive health policy are controlled by the Ministry of Health. In order to be sold in Brazil, a contraceptive device must be registered with ANVISA. Examining the product's quality, effectiveness, and safety as well as the production process and facilities are all part of the registration procedure. Brazil has tight guidelines for quality control that manufacturers of contraceptive methods must follow, including Good Manufacturing practices (GMP) and quality control testing.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Contraceptive Devices Market Segmentation

By Type (Revenue, USD Billion):

A condom is a sheath-shaped barrier device used during sexual intercourse to reduce the probability of pregnancy or a sexually transmitted infection (STI). There are both male and female condoms. With proper use, women whose partners use male condoms experience a 2% per-year pregnancy rate. Their use greatly decreases the risk of gonorrhea, chlamydia, trichomoniasis, hepatitis B, and HIV/AIDS, per the World Health Organization Updates in November 2020. To a lesser extent, they also protect against genital herpes, human papillomavirus (HPV), and syphilis. Hence, the other reasons that aid the growth of the contraception devices market are the rising occurrence of STDs and the substantial increase in the population

Condoms
Diaphragms
Cervical Caps
Sponges
Vaginal Rings
Intra Uterine Devices (IUD)
Other Devices

By Gender (Revenue, USD Billion):

Based on Gender the contraceptive devices market is segmented into male and female.

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.